These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37126184)

  • 61. Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma.
    Zhu Y; Xu W; Zheng X; Zheng Z
    J Investig Med; 2019 Feb; 67(2):331-337. PubMed ID: 30258027
    [TBL] [Abstract][Full Text] [Related]  

  • 62. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
    Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F
    J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
    Gerson JN; Handorf E; Villa D; Gerrie AS; Chapani P; Li S; Medeiros LJ; Wang M; Cohen JB; Churnetski M; Hill BT; Sawalha Y; Hernandez-Ilizaliturri FJ; Kothari S; Vose JM; Bast M; Fenske T; Rao Gari SN; Maddocks KJ; Bond D; Bachanova V; Kolla B; Chavez J; Shah B; Lansigan F; Burns T; Donovan AM; Wagner-Johnston N; Messmer M; Mehta A; Anderson JK; Reddy N; Kovach AE; Landsburg DJ; Glenn M; Inwards DJ; Ristow K; Karmali R; Kaplan JB; Caimi PF; Rajguru S; Evens A; Klein A; Umyarova E; Pulluri B; Amengual JE; Lue JK; Diefenbach C; Fisher RI; Barta SK
    Blood Adv; 2023 Dec; 7(24):7393-7401. PubMed ID: 37874912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score.
    Salim R; Husby S; Winther Eskelund C; Scott DW; Holte H; Kolstad A; Räty R; Ek S; Jerkeman M; Geisler C; Sommer Kristensen L; Dahl M; Grønbæk K
    Leuk Lymphoma; 2023; 64(8):1414-1423. PubMed ID: 37259807
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases.
    Tashakori M; Kim DH; Kanagal-Shamanna R; Vega F; Miranda RN; Jain P; Wang M; Medeiros LJ; Ok CY
    Hum Pathol; 2021 Dec; 118():60-68. PubMed ID: 34655612
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma.
    Kang BW; Sohn SK; Moon JH; Chae YS; Kim JG; Lee SJ; Kim WS; Lee JJ; Lee SR; Park KU; Lee HS; Lee WS; Won JH; Park MR; Kwak JY; Kim MK; Kim HJ; Oh SY; Kang HJ; Suh C
    Blood Res; 2014 Mar; 49(1):15-21. PubMed ID: 24724062
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mantle cell lymphoma epidemiology: a population-based study in France.
    Leux C; Maynadié M; Troussard X; Cabrera Q; Herry A; Le Guyader-Peyrou S; Le Gouill S; Monnereau A
    Ann Hematol; 2014 Aug; 93(8):1327-33. PubMed ID: 24763513
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Analysis of Clinical Characteristics and Prognostic Factors of Patients with Limited-Stage Mantle Cell Lymphoma].
    Sun J; He S; Rong C; Cen H; Tan XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1123-1128. PubMed ID: 35981371
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Validation of R-MIPI and prognostic value of immunoglobulin light chain restriction in mantle cell lymphoma.
    Villegas Da Ros C; Linares Garcia M; Ortiz Zuluaga S; Javier Gonzalez K; Costa S; Roig M; Perez Rodriguez PL; Orero Castello M; Luna I; López-Pavía M; Sanchez M; Carbonell F
    Br J Haematol; 2017 Jun; 177(5):816-818. PubMed ID: 27125335
    [No Abstract]   [Full Text] [Related]  

  • 70. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
    Asaad NY; Abd El-Wahed MM; Dawoud MM
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
    [TBL] [Abstract][Full Text] [Related]  

  • 71. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
    Bomben R; Ferrero S; D'Agaro T; Dal Bo M; Re A; Evangelista A; Carella AM; Zamò A; Vitolo U; Omedè P; Rusconi C; Arcaini L; Rigacci L; Luminari S; Piccin A; Liu D; Wiestner A; Gaidano G; Cortelazzo S; Ladetto M; Gattei V
    Haematologica; 2018 May; 103(5):849-856. PubMed ID: 29472356
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma.
    Mayerhoefer ME; Riedl CC; Kumar A; Gibbs P; Weber M; Tal I; Schilksy J; Schöder H
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2760-2769. PubMed ID: 31286200
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Analysis of Clinical Characteivstics and Therapeutic Efticacy of 54 Patients with Mantle Cell Lymphoma].
    Yang P; Liu YY; An R; Zhen JF; Pang M; Zhao W; Hu K; Wan W; Ke XY; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1336-1342. PubMed ID: 30295247
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors.
    Rodrigues JM; Nikkarinen A; Hollander P; Weibull CE; Räty R; Kolstad A; Amini RM; Porwit A; Jerkeman M; Ek S; Glimelius I
    Br J Haematol; 2021 May; 193(3):520-531. PubMed ID: 33686666
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma.
    He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An Aggressive Presentation of Mantle Cell Lymphoma With Unique Molecular Features.
    Inamdar AA; Loo A; Mikhail N; Lee P
    Cureus; 2021 Aug; 13(8):e17598. PubMed ID: 34646650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors.
    Gerdtsson AS; Matos Rodrigues J; Eskelund CW; Husby S; Grønbæk K; Räty R; Kolstad A; Geisler C; Porwit A; Jerkeman M; Ek S
    Haematologica; 2023 Apr; 108(4):1092-1104. PubMed ID: 36519324
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Prognostic Significance of Progression of Disease within 24 Months in Mantle Cell Lymphoma].
    Ma RX; Zhang QQ; Chen HM; Hu J; Lu FY; Han QN; Li ZY; Xu KL; Chen W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):702-707. PubMed ID: 38926956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma.
    Schaffel R; Hedvat CV; Teruya-Feldstein J; Persky D; Maragulia J; Lin D; Portlock CS; Moskowitz CH; Zelenetz AD
    Ann Oncol; 2010 Jan; 21(1):133-9. PubMed ID: 20019090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.